Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for purifying blood and delaying senescence as well as preparation method and application of pharmaceutical composition

A composition and drug technology, applied in the direction of drug combination, blood diseases, medical formula, etc., can solve problems such as "unstoppable" diseases, and achieve the effects of simple and economical procedures, improved microcirculation, and stable processes

Inactive Publication Date: 2017-12-29
严海铭
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In recent years, although there are western medicine and western medicine attacking the superficial, Chinese medicine and Chinese medicine are based on the principle, but they cannot cut off the source of "disease from the mouth", forming a low-level cycle state in which the sick are treated again, and the cured are sick again

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for purifying blood and delaying senescence as well as preparation method and application of pharmaceutical composition
  • Pharmaceutical composition for purifying blood and delaying senescence as well as preparation method and application of pharmaceutical composition
  • Pharmaceutical composition for purifying blood and delaying senescence as well as preparation method and application of pharmaceutical composition

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0031] In addition, for the pharmaceutical composition of the present invention, the present invention specially designed a preparation method, comprising the following steps:

[0032] S101: Pulverize each raw material component, then perform microwave extraction on the raw material components except Panax notoginseng powder, astaxanthin and ginseng, and extract the ginseng with supercritical CO 2 Fluid is extracted. Among them, during the pulverization process of the raw material components, notoginseng is pulverized at 0°C; microwave extraction specifically includes: the temperature is 55°C-65°C, the time is 60min-100min, and the mass of the extract is the total mass of the remaining raw material components 5-10 times of that; the raw material components of the extract include a mixed solution of water, citric acid and sodium chloride in the order of mass ratio (80-100):(3-5):1.

[0033] S102: Combining microwave extraction and supercritical CO 2 The products after fluid e...

Embodiment 1

[0037] The invention provides a pharmaceutical composition. The raw material components are composed of the following raw material components in parts by weight: 50 parts by weight of notoginseng powder, 30 parts by weight of corn peptide, 5 parts by weight of astaxanthin and 23 parts by weight of ginseng.

[0038] According to the above raw material components, adopt the preparation method provided by the invention to prepare the pharmaceutical composition:

[0039] S101: Pulverize each raw material component, then perform microwave extraction on the raw material components except Panax notoginseng powder, astaxanthin and ginseng, and extract the ginseng with supercritical CO 2Fluid is extracted. Among them, during the pulverization process of the raw material components, notoginseng was pulverized at 0°C; microwave extraction specifically included: the temperature was 55°C, the time was 100 min, and the mass of the extract was 10 times the total mass of the remaining raw mat...

Embodiment 2

[0043] The invention provides a pharmaceutical composition. The raw material components are composed of the following raw material components in parts by weight: 60 parts by weight of notoginseng powder, 5 parts by weight of corn peptide, 10 parts by weight of astaxanthin and 18 parts by weight of ginseng.

[0044] According to the above raw material components, adopt the preparation method provided by the invention to prepare the pharmaceutical composition:

[0045] S101: Pulverize each raw material component, then perform microwave extraction on the raw material components except Panax notoginseng powder, astaxanthin and ginseng, and extract the ginseng with supercritical CO 2 Fluid is extracted. Among them, during the pulverization process of the raw material components, notoginseng was pulverized at 0°C; microwave extraction specifically included: the temperature was 65°C, the time was 60 minutes, and the mass of the extract was 5 times the total mass of the remaining raw ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to pharmaceutical composition for purifying blood and delaying senescence as well as a preparation method and an application of the pharmaceutical composition. The pharmaceutical composition is prepared from raw material components as follows: notoginseng powder, corn peptide, astaxanthin and radix ginseng. The preparation method comprises steps as follows: the raw material components are crushed, the raw material components excluding the notoginseng powder, corn peptide, astaxanthin and radix ginseng are subjected to microwave extraction, the radix ginseng is subjected to extraction through supercritical CO2 liquids; products obtained after microwave extraction and extraction with the supercritical CO2 liquids are mixed and filtered, and filtrate is collected and cooled to 5-10 DEG C; the notoginseng powder and the astaxanthin are sequentially added to the cooled products and mixed uniformly, and the pharmaceutical composition is obtained. The provided pharmaceutical composition is prepared from natural active components serving as the raw material components through scientific matching, is safe, has not toxic or side effects, has excellent efficacy of reducing pressure and lipid, purifying blood, delaying senescence delaying, alleviating a hangover, improving the oxidation resistance of a body and further enhancing the immunity of the body and has broad application value.

Description

technical field [0001] The invention relates to the technical field of Chinese herbal medicines, in particular to a pharmaceutical composition for purifying blood and delaying aging, a preparation method and application thereof. Background technique [0002] With the rapid economic development and the change of dietary pattern, people's life rhythm is obviously accelerated; On the other hand, people’s mental labor components increase and physical labor components decrease, which often leads to an imbalance in the digestive and absorption system, which in turn leads to deficiency of Qi and blood, lack of energy, dizziness, palpitations, Insomnia, forgetfulness and other symptoms. Fat accumulates in the body, the blood is acidic, social entertainment, work pressure, work and rest disorder, lack of time to exercise, excessive smoking and alcohol, etc., will lead to metabolic disorders in the body, often feeling lack of energy, fatigue and drowsiness, and decreased resistance. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/02A61P7/00A61P39/06A61P9/12A61P3/06A61P39/02A61P37/04A61P9/10A23L33/105A23L33/18A23L2/52A61K36/258A61K36/8969A61K36/8984A61K31/122
CPCA23L2/52A23L33/105A23L33/18A61K31/122A61K36/185A61K36/258A61K36/62A61K36/73A61K36/815A61K36/8969A61K36/8984A61K38/02A61K2236/37A61K2300/00
Inventor 严海铭
Owner 严海铭
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com